Circulating CCR6 + ILC proportions are lower in multiple sclerosis patients

The role of innate lymphoid cells (ILC), particularly helper ILC, in the pathogenesis of multiple sclerosis (MS) is not well understood. Here, we present a comprehensive analysis of peripheral ILC subsets in MS patients prior and after alemtuzumab administration using mass cytometry.

• Publication year

  2022

• Venue

  Clinical & Translational Immunology

• Publication date

  2022-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/cti2.1426PMID 36578284PMCID 9782758
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Peripheral B‐cell dysregulation is associated with relapse after long‐term quiescence in patients with multiple sclerosis

  2022cited by this paper
• Natural killer cells in inflammatory autoimmune diseases

  2021cited by this paper
• CCR6-CCL20 axis as a therapeutic target for autoimmune diseases.

  2021influential reference
• Antigen-presenting innate lymphoid cells orchestrate neuroinflammation

  2021cited by this paper
• Integration, exploration, and analysis of high-dimensional single-cell cytometry data using Spectre

  2020cited by this paper
• Type 2 Innate Lymphoid Cells Induce CNS Demyelination in an HSV-IL-2 Mouse Model of Multiple Sclerosis

  2020influential reference
• Repopulation of T, B, and NK cells following alemtuzumab treatment in relapsing-remitting multiple sclerosis

  2020influential reference
• CD56bright Natural Killer Cells: A Possible Biomarker of Different Treatments in Multiple Sclerosis

  2020cited by this paper
• Immune monitoring using mass cytometry and related high-dimensional imaging approaches

  2019cited by this paper
• Immunological Aspects of Approved MS Therapeutics

  2019cited by this paper
• Live Cell Barcoding for Efficient Analysis of Small Samples by Mass Cytometry.

  2019cited by this paper
• Fingolimod Alters Tissue Distribution and Cytokine Production of Human and Murine Innate Lymphoid Cells

  2019influential reference
• Immune reconstitution therapies: concepts for durable remission in multiple sclerosis

  2019cited by this paper
• Innate Lymphoid Cells: 10 Years On.

  2018cited by this paper
• Alemtuzumab for the treatment of multiple sclerosis

  2018cited by this paper
• Mast Cells and Innate Lymphoid Cells: Underappreciated Players in CNS Autoimmune Demyelinating Disease

  2018cited by this paper
• Innate lymphoid cells in autoimmunity and chronic inflammatory diseases

  2018cited by this paper
• Human innate lymphoid cells (ILCs): Toward a uniform immune‐phenotyping

  2018cited by this paper
• Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.

  2017cited by this paper
• (T)Betting on innate lymphoid cells in CNS inflammatory disease

  2017cited by this paper
• Functional and phenotypic heterogeneity of group 3 innate lymphoid cells

  2017cited by this paper
• Distinct pattern of lesion distribution in multiple sclerosis is associated with different circulating T-helper and helper-like innate lymphoid cell subsets

  2017cited by this paper
• Fast Interpolation-based t-SNE for Improved Visualization of Single-Cell RNA-Seq Data

  2017cited by this paper
• Alemtuzumab treatment alters circulating innate immune cells in multiple sclerosis

  2016influential reference
• Increased prevalence of lymphoid tissue inducer cells in the cerebrospinal fluid of patients with early multiple sclerosis

  2016influential reference
• Mass Cytometry: Single Cells, Many Features.

  2016cited by this paper
• Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation

  2016cited by this paper
• Daclizumab reverses intrathecal immune cell abnormalities in multiple sclerosis

  2015cited by this paper
• Brief Report: Enrichment of Activated Group 3 Innate Lymphoid Cells in Psoriatic Arthritis Synovial Fluid

  2015cited by this paper
• Role of the innate and adaptive immune responses in the course of multiple sclerosis.

  2015cited by this paper
• R: A language and environment for statistical computing.

  2014cited by this paper
• Fitting Linear Mixed-Effects Models Using lme4

  2014cited by this paper
• Innate lymphoid cells — a proposal for uniform nomenclature

  2013cited by this paper
• Inhibition of LTi Cell Development by CD25 Blockade Is Associated with Decreased Intrathecal Inflammation in Multiple Sclerosis

  2012cited by this paper
• Permutation Tests for Random Effects in Linear Mixed Models

  2012cited by this paper
• Role of the innate immune system in the pathogenesis of multiple sclerosis.

  2010cited by this paper
• Randomization, Bootstrap and Monte Carlo Methods in Biology

  2007cited by this paper

• Innate lymphoid cells: unsung heroes or villains in multiple sclerosis pathogenesis?

  2026cites this paper
• Role of innate immune cells in multiple sclerosis

  2025cites this paper
• Double positive IL-17A+IFN-γ+CCR6+ ILCs contribute towards the immunopathology of lepromatous leprosy.

  2025cites this paper
• Retinoic acid modulates peripheral blood helper innate lymphoid cell composition in vitro in patients with multiple sclerosis.

  2024cites this paper
• Understanding Multiple Sclerosis Pathophysiology and Current Disease-Modifying Therapies: A Review of Unaddressed Aspects.

  2024cites this paper
• Estriol and commensal microflora strains regulate innate lymphoid cells functional activity in multiple sclerosis.

  2024cites this paper
• The role of CD56bright NK cells in neurodegenerative disorders

  2024cites this paper
• ILC3: a case of conflicted identity

  2023cites this paper